KRAS and pancreatic neoplasm: Consistent with our observation that KRAS protein expression levels decreased after MALAT1 knockdown was our observation that MALAT1 knockdown also downregulated the MAPK signalling pathway, which is constitutively activated in pancreatic tumours.